A: For the diagnosis of new coronavirus pneumonia patients incurred medical costs, by the basic health insurance, major disease insurance, medical assistance, etc., in accordance with the provisions of the payment, the individual part of the burden by the financial subsidies, the implementation of a comprehensive protection.
2. What is the policy for reimbursement of medical expenses for suspected patients, and what are the provisions for reimbursement of expenses for continued hospitalization after exclusion of suspicion?
Answer: the suspected patients to implement the confirmed patient health insurance payment policy, after the exclusion of the suspected, but still need to continue hospitalization costs incurred, but also to continue to implement the confirmed patient health insurance reimbursement policy, the entire cost of the discharge of the hospital and settlement.
3. Does the patient need to pay for the expenses in advance?
A: the new coronavirus pneumonia patients, adhere to the urgent, special, the opening of the green channel of health insurance, regardless of whether the insurance, whether for referral to hospitals, whether to apply for the record of foreign medical procedures, whether it can be a network of foreign settlements, the implementation of the first treatment and then settle the costs of the health insurance fund first advanced, individuals do not need to pay.
4. What are the provisions of the medical insurance for the drugs and medical services used by patients? What is the specific reimbursement policy?
A: the new coronavirus pneumonia patients using drugs and medical services, in line with the health sector to develop diagnostic and treatment programs, all included in the scope of payment of the health insurance fund, of which the scope of medicines, diagnostic and therapeutic items within the scope of the health insurance directory, there is a limit to the scope of payment of the temporary abolition of restrictions on reimbursement ratios in accordance with the implementation of the original health insurance policy; directory outside the scope of the medicines and diagnostic and therapeutic items, the temporary inclusion of the health insurance Drugs and diagnostic and therapeutic items outside the scope of the catalog are temporarily included in the scope of medical insurance, the first out-of-pocket payment ratio of individuals for diagnostic and therapeutic items is zero, and drugs are reimbursed according to Category A. For clinically necessary drugs and treatment items that are not included in the diagnosis and treatment program for the time being, they will be managed according to the medical insurance payment policy for drugs and treatment items in the diagnosis and treatment program.
5. For the treatment of new coronavirus pneumonia patients with new medical services need to establish a project, how to determine the specific price? How to realize the medical insurance settlement payment?
A: During the epidemic, the new medical services for the treatment of patients with new coronavirus pneumonia, do not need to go through the process of new projects, can be directly determined by the designated treatment of medical institutions to determine the use of specific prices in accordance with the principles of pricing of the cost measurement pricing, shall not deviate from the cost of pricing is too high. By the medical insurance agency into the medical insurance settlement system, given the settlement code, the medical institutions corresponding settlement.
6. During the epidemic, for the province allowed to transfer the use of traditional Chinese medicine from the preparation of medical insurance reimbursement?
A: During the epidemic, the provincial Drug Administration and the Provincial Health Commission to determine the province allowed to transfer the use of traditional Chinese medicine from the preparation, included in the scope of payment of health insurance, the specific reimbursement rate by the city in accordance with the relevant provisions of the local self-preparation to determine.
7. Can medicines and medical consumables needed for epidemic prevention and treatment be purchased offline?
A: During the epidemic, the drugs and medical consumables required for the prevention and control of the epidemic opened up a green channel for procurement, the designated medical institutions can be offline emergency procurement, direct contact with manufacturers, in accordance with the principle of fairness and reasonable determination of the purchase price, to protect the clinical needs of medical institutions.
8. How is the relaxation of long-term prescriptions for patients with chronic diseases during the epidemic mastered?
A: In order to reduce the risk of cross-infection brought about by patients traveling to and from the hospital many times, during the epidemic prevention and control, hypertension, diabetes and other stable conditions and the need for long-term use of fixed medication for chronic diseases, according to the needs of chronic diseases and diagnosis and treatment of the provisions of the amount of medication can be relaxed to three months, but the patient must follow the doctor's instructions to take the medication. The prescription of traditional Chinese medicine for some chronic diseases can be relaxed to two weeks. For discharge necessary to bring drugs can also be appropriately relaxed according to the needs of the disease.
9. Due to the impact of the epidemic, flexible employment and urban and rural residents are unable to handle the insurance payment business on schedule, can they be allowed to extend the process?
Answer: flexible employment and urban and rural residents to pay health insurance premiums to relax the time limit requirements, failing to handle the timely participation in the payment of premiums, allowed to make up for the end of the epidemic within three months to make up for the payment of premiums, does not affect the participants to enjoy the benefits.
10. Will the medical insurance reimburse the cost of consumables such as protective gear used by medical personnel?
A: According to the National Ministry of Finance, Finance and Social [2020] No. 2 document: medical and health institutions to carry out epidemic prevention and control of protection, diagnosis and treatment of special equipment and rapid diagnostic reagents purchasing the funds required by the local finance to be arranged, the central government as appropriate to give subsidies.